UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 45

Sortiert nach

Nitrous oxide misuse and vitamin B12 deficiency

BMJ case reports, 2016-05, Vol.2016

2016

Volltextzugriff (PDF)

The SANAD II study of the effectiveness and cost-effectiveness of valproate versus levetiracetam for newly diagnosed generalised and unclassifiable epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial

The Lancet (British edition), 2021-04, Vol.397 (10282), p.1375-1386

2021

Volltextzugriff (PDF)

The SANAD II study of the effectiveness and cost-effectiveness of levetiracetam, zonisamide, or lamotrigine for newly diagnosed focal epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial

The Lancet (British edition), 2021-04, Vol.397 (10282), p.1363-1374

2021

Volltextzugriff (PDF)

Nitrous oxide misuse and vitamin B 12 deficiency

BMJ case reports, 2016-05, p.bcr2016215728

2016

Volltextzugriff (PDF)

Covid-19: Ending free testing is a mistake

BMJ (Online), 2022-04, Vol.377, p.o936

Pickersgill, Trevor

2022

Volltextzugriff (PDF)

Clinical Outcomes of Escalation vs Early Intensive Disease-Modifying Therapy in Patients With Multiple Sclerosis

JAMA neurology, 2019-05, Vol.76 (5), p.536

2019

Volltextzugriff (PDF)

Demographic and clinical factors associated with changes in employment in multiple sclerosis

Multiple sclerosis, 2013-10, Vol.19 (12), p.1647-1654

2013

Volltextzugriff (PDF)

Contemporary study of multiple sclerosis disability in South East Wales

Journal of neurology, neurosurgery and psychiatry, 2023-04, Vol.94 (4), p.272

2023

Volltextzugriff (PDF)

The European working time directive for doctors in training

BMJ (Online), 2001-12, Vol.323 (7324), p.1266

Pickersgill, T

International edition, 2001

Volltextzugriff (PDF)

Complement regulator factor H as a serum biomarker of multiple sclerosis disease state

Brain (London, England : 1878), 2010-06, Vol.133 (6), p.1602-1611

2010

Volltextzugriff (PDF)

Clinical relevance of differential lymphocyte recovery after alemtuzumab therapy for multiple sclerosis

Neurology, 2013-01, Vol.80 (1), p.55

2013

Volltextzugriff (PDF)

How common is truly benign MS in a UK population?

Journal of neurology, neurosurgery and psychiatry, 2019-05, Vol.90 (5), p.522

2019

Volltextzugriff (PDF)

Impact of the 2017 revisions to McDonald criteria on the diagnosis of multiple sclerosis

Multiple sclerosis, 2018-11, Vol.24 (13), p.1786-1787

2018

Volltextzugriff (PDF)

Long-term outcome of paediatric-onset multiple sclerosis: a population-based study

Journal of neurology, neurosurgery and psychiatry, 2013-02, Vol.84 (2), p.141-147

2013

Volltextzugriff (PDF)

Multiple sclerosis relapses and depression

Journal of psychosomatic research, 2012-10, Vol.73 (4), p.272-276

2012

Volltextzugriff (PDF)

Seasonal variation in multiple sclerosis relapse

Journal of neurology, 2017-06, Vol.264 (6), p.1059-1067

2017

Volltextzugriff (PDF)

Contribution of relapses to disability in multiple sclerosis

Journal of neurology, 2008-02, Vol.255 (2), p.280-287

2008

Volltextzugriff (PDF)

Temporal evolution of remission following multiple sclerosis relapse and predictors of outcome

Multiple sclerosis, 2012-08, Vol.18 (8), p.1152-1158

2012

Volltextzugriff (PDF)

Cluster of atypical adult Guillain-Barré syndrome temporally associated with neurological illness due to EV-D68 in children, South Wales, United Kingdom, October 2015 to January 2016

Euro surveillance : bulletin européen sur les maladies transmissibles, 2016-01, Vol.21 (4), p.1

2016

Volltextzugriff (PDF)

The aetiology of acute neurological decline in multiple sclerosis: Experience from an open-access clinic

Multiple sclerosis, 2015-01, Vol.21 (1), p.67-75

2015

Volltextzugriff (PDF)

Modelling the natural history of primary progressive multiple sclerosis

Journal of neurology, neurosurgery and psychiatry, 2015-01, Vol.86 (1), p.13-19

2015

Volltextzugriff (PDF)

NO LAUGHING MATTER

Journal of neurology, neurosurgery and psychiatry, 2016-12, Vol.87 (12), p.e1-e1

2016

Volltextzugriff (PDF)

ATYPICAL GUILLAIN-BARRé IN THREE MONTHS IN SOUTH EAST WALES

Journal of neurology, neurosurgery and psychiatry, 2016-12, Vol.87 (12), p.e1-e1

2016

Volltextzugriff (PDF)

CONTEMPORARY ANALYSIS OF MORTALITY IN MULTIPLE SCLEROSIS

Journal of neurology, neurosurgery and psychiatry, 2016-12, Vol.87 (12), p.e1-e1

2016

Volltextzugriff (PDF)

NO TEMPORAL EFFECT ON DISABILITY IN MULTIPLE SCLEROSIS

Journal of neurology, neurosurgery and psychiatry, 2014-10, Vol.85 (10), p.e4-e4

2014

Volltextzugriff (PDF)

1 – 25 von 45

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(41)
Mit Volltextzugriff
(35)

Publikationsform

Artikel
(43)
Berichte
(2)

Sprache

Englisch
(45)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Nitrous oxide misuse and vitamin B12 deficiency

The SANAD II study of the effectiveness and cost-effectiveness of valproate versus levetiracetam for newly diagnosed generalised and unclassifiable epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial

The SANAD II study of the effectiveness and cost-effectiveness of levetiracetam, zonisamide, or lamotrigine for newly diagnosed focal epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial

Nitrous oxide misuse and vitamin B 12 deficiency

Covid-19: Ending free testing is a mistake

Clinical Outcomes of Escalation vs Early Intensive Disease-Modifying Therapy in Patients With Multiple Sclerosis

Demographic and clinical factors associated with changes in employment in multiple sclerosis

Contemporary study of multiple sclerosis disability in South East Wales

The European working time directive for doctors in training

Complement regulator factor H as a serum biomarker of multiple sclerosis disease state

Clinical relevance of differential lymphocyte recovery after alemtuzumab therapy for multiple sclerosis

How common is truly benign MS in a UK population?

Impact of the 2017 revisions to McDonald criteria on the diagnosis of multiple sclerosis

Long-term outcome of paediatric-onset multiple sclerosis: a population-based study

Multiple sclerosis relapses and depression

Seasonal variation in multiple sclerosis relapse

Contribution of relapses to disability in multiple sclerosis

Temporal evolution of remission following multiple sclerosis relapse and predictors of outcome

Cluster of atypical adult Guillain-Barré syndrome temporally associated with neurological illness due to EV-D68 in children, South Wales, United Kingdom, October 2015 to January 2016

The aetiology of acute neurological decline in multiple sclerosis: Experience from an open-access clinic

Modelling the natural history of primary progressive multiple sclerosis

NO LAUGHING MATTER

ATYPICAL GUILLAIN-BARRé IN THREE MONTHS IN SOUTH EAST WALES

CONTEMPORARY ANALYSIS OF MORTALITY IN MULTIPLE SCLEROSIS

NO TEMPORAL EFFECT ON DISABILITY IN MULTIPLE SCLEROSIS

Suchergebnisse filtern